oxazoles has been researched along with Brain Neoplasms in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (12.50) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (12.50) | 29.6817 |
| 2010's | 2 (12.50) | 24.3611 |
| 2020's | 10 (62.50) | 2.80 |
| Authors | Studies |
|---|---|
| Ballman, KV; Blinder, V; Borges, VF; Carey, LA; Goetz, MP; Irvin, WJ; Kommalapati, A; Krop, I; Lee, M; McCall, L; Mitchell, M; O'Sullivan, CC; Partridge, AH; Symmans, WF; Tung, NM; Weiss, A; Zemla, T | 1 |
| Borges, V; Cameron, D; Carey, LA; Curigliano, G; Feng, W; Gelmon, K; Hamilton, E; Hortobagyi, GN; Hurvitz, S; Krop, I; Loi, S; Loibl, S; Mueller, V; Murthy, R; Okines, A; Paplomata, E; Pegram, M; Ramos, J; Slamon, D; Winer, E | 1 |
| Bachelot, T; Bailleux, C; Darlix, A; Jacot, W | 1 |
| Ahmed, AU; Balyasnikova, IV; Burga, R; Castro, B; Cordero, A; Fares, J; Kanojia, D; Lee-Chang, C; Lesniak, MS; Miska, J; Petrosyan, E; Ramsey, MD; Rashidi, A; Schwartz, CW; Xiao, T; Zhang, P | 1 |
| Abramson, V; Anders, C; Bachelot, T; Bedard, PL; Borges, V; Braga, S; Cameron, D; Carey, LA; Curigliano, G; Duhoux, FP; Feng, W; Gelmon, K; Greil, R; Hamilton, E; Hortobagyi, G; Hurvitz, SA; Jakobsen, E; Krop, I; Lin, NU; Loi, S; Loibl, S; Müller, V; Murthy, RK; Okines, A; Oliveira, M; Palanca-Wessels, MC; Paplomata, E; Pegram, M; Shachar, SS; Slamon, D; Walker, L; Winer, EP | 1 |
| Barry, WT; Freedman, RA; Krop, I; Lawler, E; Leone, JP; Li, T; Lin, NU; Metzger Filho, O; Tan-Wasielewski, Z; Tolaney, SM; Trippa, L; Walker, L; Winer, EP; Younger, J | 1 |
| Abramson, V; An, X; Anders, C; Bachelot, T; Bedard, PL; Borges, V; Cameron, D; Carey, L; Chien, AJ; Conlin, A; Curigliano, G; DiGiovanna, MP; Gelmon, K; Hamilton, E; Hurvitz, S; Lin, NU; Loi, S; Loibl, S; Mayor, J; McGoldrick, S; Mueller, V; Murthy, RK; O'Regan, R; Okines, A; Oliveira, M; Paplomata, E; Wardley, A; Winer, EP; Zelnak, A | 1 |
| Curigliano, G; Prat, A; Tarantino, P | 1 |
| Exman, P; Tolaney, SM | 1 |
| Borsellino, N; Galanti, D; Gori, S; Incorvaia, L; Inno, A; La Vecchia, M; Russo, A | 1 |
| Coman, D; Herman, P; Huang, Y; Hyder, F; Maritim, S; Rao, JU | 1 |
| Chen, Y; Cheng, YC; Hsieh, CH; Hueng, DY; Tsai, WC | 1 |
| Hazama, M; Maekawa, T; Momose, Y; Murase, K; Sakai, N; Sugiyama, Y; Tawada, H | 1 |
| Anway, MD; Nilsson, EE; Skinner, MK; Stanfield, J | 1 |
| Dhawan, V; Ginos, JZ; Jarden, JO; Junck, L; Kearfott, KJ; Rottenberg, DA | 1 |
| Arnold, JB; Junck, L; Rottenberg, DA | 1 |
3 review(s) available for oxazoles and Brain Neoplasms
| Article | Year |
|---|---|
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Blood-Brain Barrier; Brain Neoplasms; Breast Neoplasms; Capecitabine; Cranial Irradiation; Disease Progression; Female; Humans; Lapatinib; Life Expectancy; Magnetic Resonance Imaging; Metastasectomy; Middle Aged; Oxazoles; Pyridines; Quinazolines; Quinolines; Radiosurgery; Receptor, ErbB-2; Receptors, Estrogen; Trastuzumab | 2021 |
HER2-positive metastatic breast cancer: a comprehensive review.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Breast Neoplasms; Bridged-Ring Compounds; Camptothecin; Female; Humans; Immunoconjugates; Neoplasm Metastasis; Oxazoles; Pyridines; Quinazolines; Receptor, ErbB-2; Taxoids; Trastuzumab | 2021 |
Current treatment options for HER2-positive breast cancer patients with brain metastases.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Breast Neoplasms; Humans; Oxazoles; Pyridines; Quality of Life; Quinazolines; Receptor, ErbB-2; Trastuzumab | 2021 |
5 trial(s) available for oxazoles and Brain Neoplasms
| Article | Year |
|---|---|
Alliance A011801 (compassHER2 RD): postneoadjuvant T-DM1 + tucatinib/placebo in patients with residual HER2-positive invasive breast cancer.
Topics: Ado-Trastuzumab Emtansine; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Breast; Breast Neoplasms; Chemoradiotherapy, Adjuvant; Chemotherapy, Adjuvant; Clinical Trials, Phase III as Topic; Disease-Free Survival; Double-Blind Method; Female; Follow-Up Studies; Humans; Mastectomy; Middle Aged; Multicenter Studies as Topic; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm, Residual; Oxazoles; Placebos; Prospective Studies; Pyridines; Quinazolines; Randomized Controlled Trials as Topic; Receptor, ErbB-2 | 2021 |
Tucatinib versus placebo added to trastuzumab and capecitabine for patients with pretreated HER2+ metastatic breast cancer with and without brain metastases (HER2CLIMB): final overall survival analysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Breast Neoplasms; Capecitabine; Disease-Free Survival; Female; Humans; Oxazoles; Pyridines; Quinazolines; Receptor, ErbB-2; Survival Analysis; Trastuzumab | 2022 |
Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Breast Neoplasms; Capecitabine; Consolidation Chemotherapy; Diarrhea; Double-Blind Method; Female; Humans; Kaplan-Meier Estimate; Middle Aged; Oxazoles; Progression-Free Survival; Protein-Tyrosine Kinases; Pyridines; Quinazolines; Receptor, ErbB-2; Trastuzumab | 2020 |
Phase I dose-escalation trial of tucatinib in combination with trastuzumab in patients with HER2-positive breast cancer brain metastases.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Breast Neoplasms; Humans; Oxazoles; Pyridines; Quinazolines; Receptor, ErbB-2; Trastuzumab; Treatment Outcome | 2020 |
Intracranial Efficacy and Survival With Tucatinib Plus Trastuzumab and Capecitabine for Previously Treated HER2-Positive Breast Cancer With Brain Metastases in the HER2CLIMB Trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Breast Neoplasms; Capecitabine; Disease Progression; Double-Blind Method; Female; Humans; Middle Aged; Oxazoles; Pyridines; Quinazolines; Receptor, ErbB-2; Trastuzumab; Young Adult | 2020 |
8 other study(ies) available for oxazoles and Brain Neoplasms
| Article | Year |
|---|---|
Combination of tucatinib and neural stem cells secreting anti-HER2 antibody prolongs survival of mice with metastatic brain cancer.
Topics: Animals; Antineoplastic Agents, Immunological; Brain Neoplasms; Cell Line, Tumor; Humans; Mice; Mice, Nude; Neoplasm Metastasis; Neoplasms, Experimental; Neural Stem Cells; Oxazoles; Pyridines; Quinazolines; Receptor, ErbB-2; Xenograft Model Antitumor Assays | 2022 |
New anti-HER2 agents for brain metastasis: histology-agnostic weapons?
Topics: Antineoplastic Agents; Brain Neoplasms; Breast Neoplasms; Female; Humans; Oxazoles; Pyridines; Quinazolines; Receptor, ErbB-2; Trastuzumab | 2021 |
Towards longitudinal mapping of extracellular pH in gliomas.
Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Glioma; Hydrogen-Ion Concentration; Magnetic Resonance Imaging; Male; Molecular Probe Techniques; Molecular Probes; Oxazoles; Pyrimidinones; Rats; Rats, Inbred F344; Rats, Sprague-Dawley; Reproducibility of Results; Sensitivity and Specificity | 2016 |
Cordycepin inhibits migration of human glioblastoma cells by affecting lysosomal degradation and protein phosphatase activation.
Topics: Ammonium Chloride; Animals; Antineoplastic Agents; Apoptosis; Brain Neoplasms; Cell Line, Tumor; Cell Movement; Deoxyadenosines; Enzyme Activation; Enzyme Inhibitors; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Lysosomes; Marine Toxins; Mice, Nude; Neoplasm Proteins; Okadaic Acid; Oxazoles; Phosphoprotein Phosphatases; Proteolysis; Tumor Burden; Xenograft Model Antitumor Assays | 2017 |
Synthesis and biological activity of novel 5-(omega-aryloxyalkyl)oxazole derivatives as brain-derived neurotrophic factor inducers.
Topics: Alkanes; Animals; Blood Glucose; Body Weight; Brain Chemistry; Brain Neoplasms; Brain-Derived Neurotrophic Factor; Cell Line, Tumor; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Humans; Indicators and Reagents; Magnetic Resonance Spectroscopy; Male; Neural Conduction; Neuroblastoma; Oxazoles; Rats; Rats, Sprague-Dawley; Reaction Time; Stimulation, Chemical; Structure-Activity Relationship; Subcellular Fractions | 2003 |
Transgenerational epigenetic effects of the endocrine disruptor vinclozolin on pregnancies and female adult onset disease.
Topics: Age of Onset; Animals; Brain Neoplasms; Breeding; Endocrine Disruptors; Epigenesis, Genetic; Female; Fungicides, Industrial; Kidney Diseases; Kidney Neoplasms; Male; Maternal Exposure; Oxazoles; Pregnancy; Pregnancy Complications; Prenatal Exposure Delayed Effects; Rats; Rats, Sprague-Dawley; Toxicity Tests, Chronic | 2008 |
In vivo measurement of brain tumor pH using [11C]DMO and positron emission tomography.
Topics: Adult; Brain Neoplasms; Carbon Radioisotopes; Dimethadione; Female; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Oxazoles; Tomography, Emission-Computed | 1985 |
In vivo measurement of regional brain and tumor pH using [14C]dimethyloxazolidinedione and quantitative autoradiography.
Topics: Animals; Autoradiography; Brain Chemistry; Brain Neoplasms; Carbon Radioisotopes; Dimethadione; Extracellular Space; Glioma; Hydrogen-Ion Concentration; Intracellular Fluid; Male; Oxazoles; Rats; Rats, Inbred Strains | 1985 |